Treatment of cells with this new PROTAC also induced efficient degradation of both c-IAP1 and CRABP-2 and blocked proliferation of neuroblastoma cells; however, the effects on either c-IAP2 or XIAP were not analysed [100]. The gene discussed is CRABP2; the disease is neuroblastoma.